Secretive Project Prometheus takes VC Bob Nelsen beyond just health care
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
Investor Noubar Afeyan warns against a backlash to science in the U.S.
SAN FRANCISCO — Noubar Afeyan, one of biotech’s top investors, warned in an annual letter that a backlash…
Childhood vaccine schedule slashed, ‘unknown risks’ of vaccination cited
WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response to an…
Opinion: The miracle of curing Alzheimer’s? No longer an impossibility. – MarketWatch
Opinion: The miracle of curing Alzheimer’s? No longer an impossibility. MarketWatch New study shows Alzheimer’s disease can be reversed…
Pfizer, FDA, BioMarin, worst CEO of 2025: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
UnitedHealth Group releases results of independent audit
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound
Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight…
Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay off
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks…